MDL | - |
---|---|
Molecular Weight | 620.18 |
Molecular Formula | C31H30ClN5O3S2 |
SMILES | OC(C1=C(CCCOC2=CC=C(CN)C=C2)SC(C3=CC4=C(CCC/C4=N\NC5=NC(C=CC=C6)=C6S5)C=C3)=N1)=O.[H]Cl |
WEHI-539 hydrochloride is a selective inhibitor of Bcl-XL with an IC 50 of 1.1 nM.
Bcl-xL 1.1 nM (IC 50 ) |
WEHI-539 hydrochloride is a selective inhibitor of Bcl-X L . WEHI-539 augments NSC 241240 induced caspase 3/7 activity, PARP cleavage and annexin V labelling. WEHI-539 as a single agent causes noticeable PARP cleavage in Ovcar-4 (5 μM in Ovcar-4.) and Ovsaho (1 μM in Ovsaho) cells [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
DMSO : 50 mg/mL ( 80.62 mM ; Need ultrasonic)
H 2 O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 1.6124 mL | 8.0622 mL | 16.1244 mL |
5 mM | 0.3225 mL | 1.6124 mL | 3.2249 mL |
10 mM | 0.1612 mL | 0.8062 mL | 1.6124 mL |
Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)
Solubility: ≥ 2.5 mg/mL (4.03 mM); Suspended solution